Profile of etodolac: pharmacokinetic evaluation in special populations.
about
Overexpression of cyclooxygenase-2 in malignant peripheral nerve sheath tumor and selective cyclooxygenase-2 inhibitor-induced apoptosis by activating caspases in human malignant peripheral nerve sheath tumor cells.Pain in chronic kidney disease: a scoping review.A diclofenac suppository-nabumetone combination therapy for arthritic pain relief and a monitoring method for the diclofenac binding capacity of HSA site II in rheumatoid arthritis.Drug treatment of arthritis. Update on conventional and less conventional methods.Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
P2860
Profile of etodolac: pharmacokinetic evaluation in special populations.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Profile of etodolac: pharmacokinetic evaluation in special populations.
@en
type
label
Profile of etodolac: pharmacokinetic evaluation in special populations.
@en
prefLabel
Profile of etodolac: pharmacokinetic evaluation in special populations.
@en
P356
P1476
Profile of etodolac: pharmacokinetic evaluation in special populations.
@en
P2093
Lasseter KC
P356
10.1007/BF02214107
P478
P577
1989-03-01T00:00:00Z